2013
Overview
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant commonly prescribed for depression, anxiety disorders, and related psychiatric conditions. Research published in Pancreas has examined paroxetine in the context of pharmacovigilance and drug safety monitoring, specifically through analysis of hospital episodes related to antidepressant overdose. This work has explored how hospital admission data can serve as an underutilized resource for tracking adverse events and overdose patterns associated with antidepressants including paroxetine. The investigation of such episodes provides valuable information about the real-world safety profile of these medications beyond traditional clinical trial settings. Understanding overdose patterns and hospital presentations related to paroxetine and other antidepressants matters for several reasons: it informs clinical practice regarding prescribing decisions and patient monitoring, contributes to broader pharmacovigilance efforts that track medication safety across populations, and highlights the potential of hospital episode data as a systematic source for identifying drug-related harms. This research underscores the importance of leveraging diverse data sources to enhance medication safety surveillance and improve patient outcomes in psychiatric pharmacotherapy.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.